Ocular Surface Disease

Related by string. * ocular : ocular itching associated . ocular itching . ocular discomfort . ocular melanoma . ocular inflammation / SURFACE . SURFACES . Surfaces . surfaces : Surface Transportation Board . Naval Surface Warfare . lightly floured surface . artificial surfaces / diseases . Diseases . DISEASE . DISEASES : Treat Diseases Inc. . mad cow disease . Disease Control . heart disease * *

Related by context. All words. (Click for frequent words.) 74 Crohn Disease Activity 70 NIH CPSI 69 OSDI 67 pain subscale 67 Disease Activity 67 Brief Psychiatric 65 Erectile Function IIEF 65 Female Sexual Function 65 HOMA IR 65 Score DAS 65 Montgomery Åsberg Depression 65 SARAH BURNETT • 64 Score IPSS 64 Alzheimer Disease Assessment 64 Erectile Function 64 Rating Scale BPRS 64 ADAS cog 64 EQ 5D 64 ADAS Cog 64 Risk Stratification 64 Integrated Pulmonary 64 Main Outcome Measures 63 ADCS CGIC 63 albumin excretion rate 63 DAS# CRP 63 CFQ R 63 ankle brachial 63 Severity MSCS score 63 interobserver 63 Brief Pain 63 Dyspnea 62 Assessment Questionnaire 62 bronchial hyperresponsiveness 62 UPDRS 62 Montgomery Asberg Depression 62 spirometric 62 Comorbidity 62 Global Impression CGI 62 liver histology 62 SF #v# 62 Symptom Severity 62 CDAI score 62 HAQ DI 62 Index CDAI 62 Endothelial function 62 Neuropsychiatric Inventory 62 Vitro Diagnostic Multivariate 62 WOMAC 62 Health Assessment Questionnaire 62 visceral adiposity 62 NYHA functional class 62 Foot Posture 62 Visual Analogue Scale VAS 62 Treatment Outcome 61 Mortality Risk 61 Visual Analog Scale 61 WOMAC pain 61 insulin resistance HOMA IR 61 CDAI 61 HealthShares TM Diagnostics 61 Main Outcome Measure 61 PSQI 61 Fibromyalgia Impact Questionnaire 61 left ventricular diastolic 61 PANSS 61 NAR Housing Affordability 61 YMRS 61 Joshua Coman 61 Endocrine Therapy 61 interrater reliability 61 Functional Assessment 61 International Prostate Symptom 61 Score DAS# 61 Ejection Fraction 61 Depressive symptoms 61 Scale PANSS 61 Psoriasis Area 61 Nocturia 61 CHADS2 60 Orthostatic Hypotension 60 WAIS III 60 HRQL 60 hematologic parameters 60 Symptom severity 60 comorbid anxiety 60 Fund AMEX SLX 60 leukocyte counts 60 Traveler Sentiment 60 Booked Orders 60 CSI Smallcap 60 Geriatric Depression 60 Joins Russell Microcap 60 DOLLAR INDEX Dollar 60 Negative Syndrome 60 DLQI 60 Platelet Function 60 subscores 60 Pharmacodynamic 60 MarketLive Performance 60 PANSS total 60 ADCS ADL 60 EORTC QLQ C# 60 Brazil Bovespa Stock 60 airway hyperresponsiveness 60 HDRS 60 BMI z 59 Scale cognitive subscale 59 Atopic Dermatitis 59 subscore 59 Skin sterol 59 Showed Significant 59 Severity Index PASI 59 reactive hyperemia 59 SELENA SLEDAI 59 Negative Symptoms 59 dyspnoea 59 hyperhomocysteinemia 59 Pain Intensity 59 MIKE HORTON • 59 Hemodynamic 59 FOR AN OPEN 59 Expanded Disability Status 59 dyssynchrony 59 Rating Scale MADRS 59 Abnormal Involuntary Movement 59 nasal symptom 59 intraobserver 59 pulmonary arterial 59 Symptom Score 59 Histological 59 ATA Truck Tonnage 59 Interactive Healthy Eating 59 Histologic 59 NIHSS 59 Visual Analog 59 Symptom Checklist 59 demonstrated clinically meaningful 59 subscale scores 59 Healthy Behavior 59 CLAIRE DONAGHY 59 Severity Index 59 Scale EDSS score 59 Echocardiographic 59 neurocognitive function 59 AST ALT 59 IIEF 59 Depressive Symptoms 59 QIDS SR 59 aspartate aminotransferase AST 59 Sleep Disturbance 59 Hamilton Rating Scale 59 multiple linear regression 59 Cronbach alpha 59 hematological parameters 59 CIBIC plus 59 Prognostic 58 symptom severity 58 mean ± SEM 58 interobserver agreement 58 HADS 58 tissue oxygenation 58 fasting plasma 58 TNSS 58 ADHD Rating Scale 58 MADRS score 58 Albuminuria 58 Mean Symptom Complex 58 Pedestrian Danger 58 BPH Symptom Score 58 Cystic Fibrosis Questionnaire Revised 58 convergent validity 58 Score TOS 58 MMSE score 58 Clinical Outcome 58 SPADE Oklahoma 58 PCWP 58 JPMorgan Chase EMBI + 58 UPDRS Part III 58 Severity Scale 58 vitro diagnostic multivariate 58 SGRQ 58 salivary cortisol 58 HOXB# 58 Univariate 58 DAS# [002] 58 Y BOCS 58 multiple logistic regression 58 eNO 58 DAS# remission 58 Consumer Reports Trouble Tracker 58 glomerular filtration 58 corneal thickness 58 HAMD 58 leukocyte count 58 Elastography 58 microvessel density 58 premorbid 58 weakly correlated 58 Neuropsychiatric Inventory NPI 58 Inventory BPI 58 Primary endpoints 58 GfK NOP Consumer Confidence 58 STRIDE PD 58 serum BDNF 58 Conscientiousness 58 IPSS 58 SGPT 58 waist circumference WC 58 Distress Scale 58 Proteinuria 58 MDRD 58 enthesitis 58 Rating Scale UPDRS 58 aspartate aminotransferase 57 carotid IMT 57 HAM D# 57 arterial oxygen saturation 57 postprocedure 57 Insulin sensitivity 57 ACR# ACR# 57 Hepatotoxicity 57 alanine aminotransferase 57 pulmonary capillary wedge 57 Ishak fibrosis score 57 aminotransferase 57 Healthy Behaviors 57 BPRS 57 CP CPPS 57 Hypercholesterolemia 57 interobserver reliability 57 Cystatin C 57 Visual acuity 57 Chase Paymentech Pulse 57 electrophysiologic 57 Patellofemoral 57 smaller Shenzhen Component 57 Postoperative 57 foveal thickness 57 plasma cortisol 57 CORE OM 57 Lagging Indicators 57 Polysomnography 57 NIS LL 57 Scale EDSS 57 serologically active patients 57 Bonferroni correction 57 Respiratory Symptoms 57 PDSS 57 Cockcroft Gault 57 Virologic Response 57 Clinician Administered PTSD 57 cortical atrophy 57 ASA Staffing 57 somatic symptoms 57 Cardiorespiratory fitness 57 NYSE Arca Broker Dealer 57 variance ANOVA 57 Neurocognitive 57 estimated GFR 57 Neuropsychological 57 bronchoalveolar lavage 57 Thrombolysis 57 lactate dehydrogenase LDH 57 Peripheral Arterial 57 Hemoglobin A1c 57 correlation coefficients 57 HBeAg 57 Sociodemographic 57 affective psychosis 57 transcranial Doppler ultrasound 57 CRQ 57 State Examination MMSE 57 ALS Functional 57 HbA 1c levels 57 interrater 57 HRCT 57 ISM Purchasing Managers 57 HBeAg negative patients 57 echocardiographic parameters 57 erythrocyte sedimentation rate 56 seropositivity 56 autonomic dysfunction 56 Adverse Event 56 Entrex Private Company 56 Chronic Illness Therapy 56 Unified Parkinson Disease 56 Palmer Drought Severity 56 Left Ventricular 56 Outcome Measures 56 Kidney Function 56 NIHSS score 56 prespecified secondary 56 Hypotension 56 exhaled NO 56 cerebral oxygenation 56 intravascular hemolysis 56 IBDQ 56 confidence intervals CIs 56 methotrexate monotherapy 56 chi squared 56 Ischemic 56 PANSS Positive 56 AUA Symptom Score 56 idiopathic Parkinson disease 56 mg BID dose 56 Visual Analogue Scale 56 Catheter Associated 56 Cardiotoxicity 56 exploratory endpoints 56 r2 = 56 haematologic 56 Russell MicroCap 56 Heritability 56 CIPS Purchasing Managers 56 Pearson correlation coefficient 56 plasma renin activity 56 SUVmax 56 ALT AST 56 CDR Counterparty Risk 56 OSAHS 56 Pharmacologic 56 System NDIS 56 Faculty Scholarly Productivity 56 Beck Anxiety Inventory 56 corneal staining 56 Microalbuminuria 56 GH deficiency 56 hemodynamic measurements 56 Coronary artery calcium 56 Strategos wRatings Innovation 56 RECIST Response Evaluation Criteria 56 Parkinson Disease PD 56 Systolic 56 vitreous haze 56 Repeatable Battery 56 mTSS 56 depressive symptom 56 AMEX Broker Dealer 56 Claudication 56 State Exam MMSE 56 Non Responders 56 CI -#.# 56 univariate 56 CIPS NTC Purchasing Managers 56 logistic regression analysis 56 cognitive affective 56 clinicopathological 56 abdominal adiposity 56 #q# deletion syndrome 56 PsA 56 multivariable analysis 56 regression coefficient 56 urodynamic parameters 56 Myocardial Perfusion Imaging 56 metabolite concentrations 56 Chinese Shangai Composite 56 cardiac autonomic 56 clinicopathologic 56 Symptom 56 posttreatment 56 Hepatic Encephalopathy 56 FDA defined valvulopathy 56 MMSE 56 ANCOVA 56 confirmed CCyR 56 somatoform disorders 56 By FELICIA KITZMILLER 56 Suicidality 56 Status Scale EDSS 56 Profile SEP 56 Genomic Grade 56 pairwise comparisons 56 Glomerular Filtration Rate 56 Quantitation 56 myocardial reperfusion 56 bivariate 56 pulsatility 56 morphometric vertebral fractures 56 hemodynamic variables 56 Vertebral 56 nausea emesis 56 MADRS 56 Core PCE Price 56 semiquantitative 56 symptomatic intracranial hemorrhage 56 overactive bladder symptoms 56 erection hardness 56 intraclass correlation coefficients 56 IRLS score 56 nerve conduction velocity 56 serum estradiol 56 SGOT 56 subscales 55 Histopathologic 55 Functional Outcomes 55 alanine aminotransferase ALT 55 ALT elevations 55 odds ratios ORs 55 trough FEV1 55 alexithymia 55 achieved statistical significance 55 Depressive Symptomatology 55 hypoperfusion 55 Capacity FVC 55 pharmacodynamic parameters 55 Fund FXI PriceWatch 55 extrapyramidal symptoms 55 Statistically Significant 55 C Reactive Protein 55 apnea hypopnea 55 LV ejection fraction 55 Bioavailability 55 Acute Physiology 55 Mitotic 55 pulsatility index 55 Reperfusion 55 logistic regression analyzes 55 inflammatory biomarkers 55 FDG PET imaging 55 bivalirudin monotherapy 55 Adult ADHD 55 diabetes mellitus DM 55 McMaster Universities Osteoarthritis 55 Cytogenetic 55 Prognostic Value 55 INVEGA ® 55 serum triglycerides 55 Anxiety Depression 55 GRAHAM LOVE 55 Naukri Job Speak 55 radiographic findings 55 covariance ANCOVA 55 Renal Function 55 rhinoconjunctivitis 55 symptomatology 55 central corneal thickness 55 Pharmacodynamics 55 Septic Shock 55 KOOS 55 Scale Cognitive Subscale 55 Wechsler Adult 55 renal cysts 55 Kagiso Purchasing Managers 55 PLMS 55 cerebral glucose metabolism 55 anticholinergic agents 55 Gallup Job Creation 55 Erythema 55 platelet reactivity 55 Quotient TM 55 poststroke 55 Secondary efficacy endpoints 55 intraocular pressure IOP 55 FACIT Fatigue 55 esophageal reflux 55 PERMP 55 REINZ Monthly Housing 55 PPI Producer Price 55 Neuroticism 55 plasma creatinine 55 Lower Limb 55 subclinical atherosclerosis 55 Electrophysiological 55 Anthropometric 55 ‰ ¥ 55 multivariate Cox 55 mean baseline A1C 55 Diagnostic Criteria 55 Glasgow Coma Scale 55 transient elastography 55 MMSE scores 55 bivariate analysis 55 Non inferiority 55 myocardial viability 55 Nonresidential Construction 55 psychosocial variables 55 serum parathyroid hormone 55 contrast echocardiography 55 Somnolence 55 Psychometric 55 Non Alcoholic Steatohepatitis 55 oxycodone CR 55 emotional lability 55 Endothelial dysfunction 55 Subgroup analysis 55 myeloperoxidase 55 albumin excretion 55 Generalized Anxiety Disorder 55 Suboptimal 55 Morgan Stanley Cyclical 55 ISE Sentiment 55 Tasigna prolongs 55 Depression Inventory 55 estimated glomerular filtration 55 Teriflunomide 55 Psychomotor 55 vascular reactivity 55 WOMAC scores 55 PANSS scores 55 intima media thickness 55 artery stenosis 55 Neuropsychological Status 55 Myocardial Infarction TIMI 55 Patency 55 Viral load 55 tipranavir r 55 Chemotherapy induced 55 Angiographic 55 mucosal inflammation 55 Renal dysfunction 55 #OHD 55 Capsules CII 55 CNS LS 55 Fractional Flow Reserve 55 iShares MSCI Sweden 55 ascending aortic 55 Treated Patients 55 Epithelial Cell 55 BILAG 55 Multivariable 55 covariance 55 State Trait Anxiety 55 serum cortisol 55 Psychosomatic Research 55 Coronary CTA 55 WOMAC TM 55 Thrombocytopenia 55 Differential Diagnosis 55 β blockers 55 atheroma volume 55 ADHD RS 55 Stroke Scale NIHSS 55 hepatic enzymes 55 Present Situations 55 depressive symptomatology 55 Fracture Risk 55 demyelinating 55 Platelet counts 55 Fatty Liver 55 flow mediated dilatation 55 Demonstrate Significant 55 salivary flow 55 sociodemographic characteristics 55 Coincident Indicators 55 reflux esophagitis 55 univariate analyzes 55 ISE CCM Nanotechnology 55 fluorodeoxyglucose positron emission tomography 55 Cognitive Impairment 55 Market Tightness 55 meta regression 55 Acute Coronary Syndromes 55 Glomerular filtration rate 55 colorectal adenoma 55 PASI scores 54 Relapsing Remitting Multiple Sclerosis 54 VerifyNow 54 Subclinical 54 HDI Customer Satisfaction 54 T2 lesion volume 54 DSM IV Axis 54 Genetic Marker 54 Coronary Artery Calcium 54 immunohistochemical 54 unpaired t 54 Diabetic Foot Ulcer 54 APACHE II 54 glycaemia 54 Poisson regression 54 Granger causality 54 UPDRS motor 54 Dow Jones Select MicroCap 54 T2DM 54 HRQoL 54 multivariable analyzes 54 Schizophrenia Treatment 54 electroencephalographic 54 IRLS 54 Immunohistochemical 54 Preoperatively 54 T1 weighted images 54 Akathisia 54 euthymic patients 54 Stent thrombosis 54 ALT elevation 54 Haptoglobin 54 STRATEGY FOR AN OPEN 54 Arterial Hypertension 54 CRISIL MIP Blended 54 iShares MSCI Austria Investable 54 Benign Prostatic Hyperplasia 54 postoperative delirium 54 comorbid depression 54 microbiological eradication 54 periprocedural 54 elevated ALT 54 Hematocrit 54 serum leptin 54 clinically meaningful reductions 54 radiographic progression 54 Suicidal ideation 54 intima media thickness IMT 54 Secondary endpoints included 54 psychopathological symptoms 54 Seattle Angina Questionnaire 54 hepatic enzyme 54 serum lipids 54 coronary stenosis 54 NNT = 54 oxygen desaturation 54 lumbar spine BMD 54 percutaneous vertebroplasty 54 iShares MSCI EMU 54 Treating Chronic 54 Lehman Brothers Aggregate Bond 54 FXCM Speculative Sentiment 54 Virologic 54 primary aldosteronism 54 Apolipoprotein B 54 Exacerbations 54 angiographically 54 glycosylated hemoglobin HbA1c 54 MSCI Hedge Fund 54 Replikin Count 54 hematopoietic cancers 54 Rheumatoid 54 myocardial necrosis 54 recurrent venous thromboembolism 54 Demonstrated Significant 54 Predictive Value 54 myocardial infarct size 54 bothersome symptom 54 plasma leptin 54 multivariate regression analysis 54 % Confidence Interval 54 carotid stenosis 54 carotid intima media 54 Univariate analysis 54 D dimer 54 Hippocampal 54 hours postdose 54 Atomoxetine 54 Hematologic 54 Oral Fingolimod 54 Stroke Scale 54 orthostatic blood 54 Stress Induced 54 % CI #.#-#.# [008] 54 FDG-PET/CT 54 Ki# 54 unadjusted Purchase 54 #F FDG PET 54 POAG 54 postop 54 Solubility 54 IQR 54 Anticoagulant 54 Castration Resistant Prostate Cancer 54 HER2 expression 54 GPRD 54 SVME Purchasing Managers 54 noncognitive 54 Inflammatory Pain 54 Posaconazole 54 Adenomas 54 Multivariate 54 Cognitive Dysfunction 54 anemia hemoglobin 54 Solid Tumors 54 meta analytic 54 p = .# [002] 54 glycated hemoglobin levels 54 CIPS Markit Purchasing Managers 54 cough dyspnea 54 Functioning GAF 54 Comorbidities 54 baseline HbA1c 54 Descriptive statistics 54 diabetic polyneuropathy 54 Myocardial 54 psychometric properties 54 multivariable adjusted 54 fasting insulin 54 risk reducing salpingo 54 QTcF 54 Child Behavior Checklist 54 plasma pharmacokinetics 54 VTB Capital Purchasing Managers 54 HER2 overexpression 54 thickness CIMT 54 Electroencephalography 54 adenotonsillectomy 54 dysuria 54 logistic regression model 54 Regression Analysis 54 Psychiatric Illness 54 6MWD 54 Novel Compound 54 logistic regression 54 intact parathyroid hormone 54 Sexual Satisfaction 54 Arch Intern Med 54 Chronic Sinusitis 54 enzyme immunoassay EIA 54 Combo Therapy 54 Fund EWW PriceWatch 54 Overactive Bladder 54 RNFL thickness 54 MSLT 54 myocardial function 54 ALSFRS R 54 interquartile range IQR 54 ASCUS 54 Clinically significant 54 TI Corruption Perceptions 54 FTSE NAREIT Equity 54 Arrhythmogenic 54 EURIDIS 54 symptomatic VTE 54 Predict Risk 54 somatostatin analog 54 TLUS 54 Subarachnoid hemorrhage 54 neurosensory 54 artery elasticity 54 Subjective 54 subjective sleepiness 54 cerebral oxygen saturation 54 exhaled nitric oxide 54 abdominal pain abdominal discomfort 54 Randomized Evaluation 54 posttest 54 serum aminotransferase levels 54 prospective multicentre 54 allostatic load 54 Sonographic 54 By MATT ANDERSON 54 serum phosphate 54 Digit Symbol Substitution 54 Barclay Hedge Fund 54 First Episode Psychosis 54 mmHg diastolic 54 mRS 54 FluCAM arm 54 Nonalcoholic Fatty Liver Disease 54 Subscale 54 axial length 54 antiphospholipid antibodies 54 Dysmenorrhea 54 Blepharospasm 54 Postoperative complications 54 LV dysfunction 54 EUR #/#/# 53 HIV HCV coinfected 53 sargramostim 53 CLINICAL PHARMACOLOGY 53 prospectively stratified 53 Key secondary endpoints 53 HRQOL 53 Tumor Response 53 apolipoprotein B 53 -#.# mg dL [001] 53 Diastolic Heart Failure 53 symptomatic intracranial 53 Decitabine 53 troponin T 53 Cholinesterase Inhibitors 53 Adjunctive 53 tapentadol ER 53 aortic regurgitation 53 activated partial thromboplastin 53 SELENA SLEDAI score 53 multivariable logistic regression 53 -#.# ± [002] 53 Ischaemic 53 Eurozone Purchasing Managers 53 SCr 53 sensitivity specificity 53 nerve conduction velocity NCV 53 fructosamine 53 atherosclerotic renal artery stenosis 53 isoprostane 53 neutropaenia 53 nicardipine 53 pretreatment serum 53 mucosal healing 53 lumbar spine bone 53 pharmacodynamic PD 53 T2 lesions 53 Knodell necroinflammatory score 53 gastroduodenal 53 elevated IOP 53 fibrosis progression 53 Relieve Depression 53 pericardial effusion 53 postoperative complication 53 tumor perfusion 53 haemodynamic 53 XIENCE V PROMUS Stent 53 urinary albumin 53 EBMT criteria 53 binary logistic regression 53 myocardial perfusion 53 Partial Response 53 hemodynamic parameters 53 Lubiprostone 53 Severe Asthma 53 Knee Osteoarthritis 53 Clinical Relevance 53 actigraphy 53 F FDG PET 53 Serum creatinine 53 heparin induced thrombocytopenia 53 Meta Analysis 53 neurologic symptoms 53 CCyR 53 neurologic impairment 53 Polycystic ovary syndrome PCOS 53 Ischemic Stroke 53 glycosylated hemoglobin levels 53 lipid parameters 53 FTS6 techMARK 53 serum homocysteine 53 Genotypic 53 Prospective Randomized 53 Medication Adherence 53 Assessment Scale 53 umbilical artery 53 serum urate levels 53 hypophosphatemia 53 SpCO 53 PLMs 53 Multivariate logistic regression 53 nausea photophobia 53 Prev Med 53 Pearson correlation coefficients 53 hepatic lesions 53 CTEPH 53 Tertiary Industry 53 neurobehavioral functioning 53 Kinoid 53 NMIBC 53 FTMC FTSE 53 Eur Urol 53 p = .# [001] 53 Quantifiable 53 Likert scale 53 IKDC 53 Prefrontal 53 haematuria 53 serum magnesium 53 Chronic Myelogenous Leukemia 53 Edinburgh Postnatal Depression 53 Pharmacokinetic parameters 53 Cardiac Resynchronization 53 Subgroup Analysis 53 Baltic Dry Freight 53 MoxDuo TM IR 53 Myocardial Perfusion 53 gadolinium enhancing lesions 53 Logistic Regression 53 glomerular filtration rate 53 GERD symptom 53 aminotransferases 53 VFQ 53 Credit Suisse Tremont AllHedge 53 Papillary 53 BPS IC 53 neurocognitive functioning 53 renal artery stenting 53 x ULN 53 EuroSCORE 53 SLEDAI 53 methacholine challenge 53 mL/min/#.# m 2 53 dual endothelin receptor antagonist 53 EMBLEM TM 53 Congenital Heart Surgery 53 Tiotropium 53 RNFL 53 ST Segment Elevation 53 Iseq Overall 53 Wilcoxon rank sum 53 psychosocial functioning 53 preoperatively 53 anthropometric measures 53 Valvular Heart Disease 53 Pain Rating Scale 53 Consumer Reports Sentiment 53 NASDAQ Dividend Achievers 53 somatization 53 Carotid Endarterectomy 53 Gender Disparity 53 syndromic 53 Lp PLA 2 53 Uterine 53 clinico pathological 53 PSADT 53 coagulopathy 53 serum urate 53 SIMPADICO 53 Likert 53 MCID 53 Significantly Improved 53 overnight polysomnography 53 Neurophysiological 53 antibody titer 53 Functional Capacity 53 Lipodystrophy 53 histological subtype 53 bronchial responsiveness 53 polysomnographic 53 retest reliability 53 Diagnostic Accuracy 53 esophageal motility 53 International Prognostic Scoring 53 Autistic Disorder 53 HSCT 53 Genetic Variation 53 Solid Tumors criteria 53 Am J Cardiol 53 Lung Injury 53 D Dimer 53 ERalpha 53 Relapsing Multiple Sclerosis 53 Directional Movement 53 psychophysiological 53 serum thyroglobulin 53 mild renal insufficiency 53 Breslow thickness 53 Kaplan Meier estimates 53 urine NGAL 53 ACTOS ® 53 serum HBV DNA 53 donepezil Aricept 53 Percutaneous Tibial Nerve Stimulation 53 attain statistical significance 53 relapsed MM 53 Antipsychotic 53 linaclotide treated 53 Radiographic 53 Amsterdam Exchanges 53 BuySell Home Price 53 Quality Indicators 53 virological response 53 Arch Dermatol 53 urodynamic 53 orthostatic 53 creatine kinase MB 53 TPV r 53 Epworth Sleepiness Scale 53 impaired glucose metabolism 53 diastolic velocity 53 Psychodynamic Psychotherapy 53 Multidetector CT 53 Interrater reliability 53 Hypertrophy 53 Carotid Stenting 53 neuroleptic 53 Juvenile Idiopathic Arthritis 53 Impaired glucose tolerance 53 corneal curvature 53 treat NNT 53 Barclays Aggregate Bond 53 ETDRS 53 cytologic 53 Complicated Grief 53 Daptomycin 53 Hypertrophic 53 Stomatitis 53 Posttraumatic Stress 53 FSFI 53 postoperative atrial fibrillation 53 Meta Analyses 53 Homebuilder Confidence 53 total cholesterol triglycerides 53 secondary efficacy endpoint 53 Intravenous immunoglobulin 53 -#.# log# 53 Lesion 53 clinically meaningful improvement 53 pretest probability 53 APOE genotype 53 akathisia 53 Hb A1C 53 neurodevelopmental outcome 53 Non Alcoholic Fatty 53 HCV Genotype 53 oesophagitis 53 CIMZIA TM certolizumab pegol 53 ACR# response 53 VIX CBOE Volatility 53 thyroglobulin 53 psychiatric morbidity 52 icatibant 52 microvessel 52 Stable Angina 52 left ventricular systolic 52 phosphorylated tau

Back to home page